Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 1258-1263, July 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moxley, J. H.
Right arrow Articles by Frei, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moxley, J. H., III
Right arrow Articles by Frei, E., III

Intensive Combination Chemotherapy and X-irradiation in Hodgkin's Disease1

John H. Moxley, III[1],2, Vincent T. De Vita[3], Kirkland Brace[4] and Emil Frei, III[2],3

[1, 2] Medicine Branch
[3] Laboratory of Chemical Pharmacology
[4] Radiation Branch, National Cancer Institute, NIH, Bethesda, Maryland 20014

A pilot study was begun in 1963 to test the feasibility of using in the treatment of Hodgkin's disease a combination of cyclophosphamide, vincristine, methotrexate, and prednisone in full doses followed by radiotherapy where indicated. It was found that this form of therapy could be used without a prohibitive cost in toxicity. It appears that the incidence of complete remissions can be increased over that obtained with a single agent. Radiotherapy was tolerated after intensive chemotherapy, and further intensive chemotherapy was possible following high dose but limited field radiation. As expected, toxicity was increased when both modalities of therapy were employed.

The duration of complete unmaintained remission in those patients with advanced disease is provocative even though the group is small. It is our feeling that these results invite further investigation of the use of effective agents in combination.

1 Presented in part at the 56th annual meeting of The American Association for Cancer Research, April 9, 1965.

2 Present address: Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts.

3 Present address: University of Texas M. D. Anderson Hospital and Cancer Institute, Houston, Texas.

Received 10/11/66. Accepted 3/14/67.




This article has been cited by other articles:


Home page
BloodHome page
H. Brenner, A. Gondos, and D. Pulte
Ongoing improvement in long-term survival of patients with Hodgkin disease at all ages and recent catch-up of older patients
Blood, March 15, 2008; 111(6): 2977 - 2983.
[Abstract] [Full Text] [PDF]


Home page
CLIN PEDIATRHome page
F. Teillet and O. Schweisguth
Hodgkin's Disease in Children: Notes on Diagnosis and Prognosis Based on Experiences with 72 Cases in Children
Clinical Pediatrics, December 1, 1969; 8(12): 698 - 704.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.